Abstract | OBJECTIVE: DESIGN AND SETTING: A prospective study of incontinent women attending a private practice for clinical and urodynamic assessment. PATIENTS: Fifty women who had had an average of 1.8 previous operations for stress urinary incontinence took part in the study. Each had been diagnosed as having type 3 genuine stress incontinence (poor or nonfunctioning urethral sphincter mechanism in the presence of a bladder neck which is well supported, usually by scar tissue from previous surgery). Subject to a negative skin test for allergy, each patient underwent the implantation of GAX collagen ( Contigen), a biocompatible product causing no foreign body reaction. INTERVENTIONS: The implant was performed by a short day-only procedure involving cystoscopically controlled periurethral (71%) or transurethral (29%) injection of Contigen. The aim was to achieve closure of the urethra at the bladder neck and increase resistance to urine loss. Top-up injections were used as required. The follow-up period ranged from one to 21 months (mean, 11 months). RESULTS: Of these first 50 female patients, 41 (82%) were successfully treated. Twenty-one (42%) were no longer incontinent; 20 (40%) desired no further treatment because their condition was improved; seven (14%) did not respond to treatment and two patients were awaiting top-up injections. The average number of injections given was 1.9 and the average volume injected was 14.4 mL. There were no allergic reactions or infections. Side effects were temporary and of a minor nature. CONCLUSIONS:
|
Authors | P Stricker, B Haylen |
Journal | The Medical journal of Australia
(Med J Aust)
Vol. 158
Issue 2
Pg. 89-91
(Jan 18 1993)
ISSN: 0025-729X [Print] Australia |
PMID | 8419782
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Collagen
(analogs & derivatives)
- Female
- Follow-Up Studies
- Humans
- Injections
- Prospective Studies
- Prostheses and Implants
- Treatment Outcome
- Urinary Incontinence, Stress
(surgery)
|